RT-PCR Innovation Accelerates Point-of-Care Diagnostics Demand
The global Point-of-Care Molecular Diagnostics Market is entering a high-growth phase as healthcare systems increasingly prioritize rapid, decentralized, and clinically accurate diagnostic solutions. Valued at USD 5.8 billion in 2026, the market is projected to reach USD 15.1 billion by 2036, expanding at a robust 10.0% CAGR during the forecast period. Growth is being fueled by rising demand...
0 Comments 0 Shares 4 Views